FIG. 2.
(A–C) Patterns of change in sTg concentration in patients with NSED and sTg1 of (A) 2–4.9 ng/mL, (B) 5–19.9 ng/mL, (C) ≥20 ng/mL. (D) Biochemical remission rate in patients with a ≥50% decrease in sTg and those with a <50% decrease or an increase in sTg. The open dotted lines represent the serial sTg concentrations of each patient, measured every one or two years until biochemical or structural recurrence. Percent sTg change was defined as the relative change between sTg1 and sTg2.